首页> 外文期刊>Artificial Organs >Dialysis Complications in Acute Kidney Injury Patients Treated With Prolonged Intermittent Renal Replacement Therapy Sessions Lasting 10 Versus 6 Hours: Results of a Randomized Clinical Trial
【24h】

Dialysis Complications in Acute Kidney Injury Patients Treated With Prolonged Intermittent Renal Replacement Therapy Sessions Lasting 10 Versus 6 Hours: Results of a Randomized Clinical Trial

机译:持续10到6小时的长时间间歇性肾脏替代治疗治疗急性肾损伤患者的透析并发症:一项随机临床试验的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Prolonged intermittent renal replacement therapy (PIRRT) has emerged as an alternative to continuous renal replacement therapy in the management of acute kidney injury (AKI) patients. This trial aimed to compare the dialysis complications occurring during different durations of PIRRT sessions in critically ill AKI patients. We included patients older than 18 years with AKI associated with sepsis admitted to the intensive care unit and using noradrenaline doses ranging from 0.3 to 0.7 mu g/kg/min. Patients were divided into two groups randomly: in G1, 6-h sessions were performed, and in G2, 10-h sessions were performed. Seventy-five patients were treated with 195 PIRRT sessions for 18 consecutive months. The prevalence of hypotension, filter clotting, hypokalemia, and hypophosphatemia was 82.6, 25.3, 20, and 10.6%, respectively. G1 was composed of 38 patients treated with 100 sessions, whereas G2 consisted of 37 patients treated with 95 sessions. G1 and G2 were similar in male predominance (65.7 vs. 75.6%, P=0.34), age (63.6 +/- 14 vs. 59.9 +/- 15.5 years, P=0.28) and Sequential Organ Failure Assessment score (SOFA; 13.1 +/- 2.4 vs. 14.2 +/- 3.0, P=0.2). There was no significant difference between the two groups in hypotension (81.5 vs. 83.7%, P=0.8), filter clotting (23.6 vs. 27%, P=0.73), hypokalemia (13.1 vs. 8.1%, P=0.71), and hypophosphatemia (18.4 vs. 21.6%, P=0.72). However, the group treated with sessions of 10h were refractory to clinical measures for hypotension, and dialysis sessions were interrupted more often (9.5 vs. 30.1%, P=0.03). Metabolic control and fluid balance were similar between G1 and G2 (blood urea nitrogen [BUN]: 81 +/- 30 vs. 73 +/- 33mg/dL, P=1.0; delivered Kt/V: 1.09 +/- 0.24 vs. 1.26 +/- 0.26, P=0.09; actual ultrafiltration: 1731 +/- 818 vs. 2332 +/- 947mL, P=0.13) and fluid balance (-731 +/- 125 vs. -652 +/- 141mL, respectively) . In conclusion, intradialysis hypotension was common in AKI patients treated with PIRRT. There was no difference in the prevalence of dialysis complications in patients undergoing different durations of PIRRT.
机译:在急性肾损伤(AKI)患者的治疗中,长期间歇性肾脏替代治疗(PIRRT)已成为连续性肾脏替代治疗的替代方法。该试验旨在比较危重AKI患者在PIRRT疗程不同持续时间内发生的透析并发症。我们纳入了重症监护病房并使用去甲肾上腺素剂量范围为0.3至0.7μg / kg / min的18岁以上患有脓毒症相关性AKI的患者。将患者随机分为两组:在G1组进行6小时的治疗,在G2组进行10小时的治疗。 75例患者接受了195次PIRRT治疗,连续18个月。低血压,滤过器凝血,低血钾和低磷血症的患病率分别为82.6、25.3、20和10.6%。 G1由38例患者接受100疗程组成,而G2由37例患者接受95疗程组成。 G1和G2在男性优势(65.7 vs.75.6%,P = 0.34),年龄(63.6 +/- 14 vs.59.9 +/- 15.5岁,P = 0.28)和顺序器官衰竭评估得分(SOFA; 13.1)方面相似+/- 2.4与14.2 +/- 3.0,P = 0.2)。两组之间在低血压(81.5 vs. 83.7%,P = 0.8),滤网凝结(23.6 vs. 27%,P = 0.73),低钾血症(13.1 vs. 8.1%,P = 0.71),两组之间无显着差异,和低磷血症(18.4比21.6%,P = 0.72)。然而,治疗10h的组对低血压的临床措施无效,并且透析治疗更频繁地中断(9.5比30.1%,P = 0.03)。 G1和G2之间的代谢控制和体液平衡相似(血尿素氮[BUN]:81 +/- 30 vs. 73 +/- 33mg / dL,P = 1.0;递送Kt / V:1.09 +/- 0.24 vs. 1.26 +/- 0.26,P = 0.09;实际超滤:1731 +/- 818 vs. 2332 +/- 947mL,P = 0.13)和流体平衡(-731 +/- 125 vs.-652 +/- 141mL )。总之,在接受PIRRT治疗的AKI患者中,透析内低血压很常见。在接受不同持续时间的PIRRT的患者中,透析并发症的患病率没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号